Subject compensation [Study Per­for­mance]

posted by shiv – 2006-02-06 07:20 (7450 d 11:06 ago) – Posting: # 73
Views: 9,295

Dear Siva Prasad

Benifits should be proportionate to the risks involved in the study.

The subject compensation should be proportionate to the risks involved in the study (such as duration of the stay, adverse events, number of sample points, volume of the blood, number of ambulatory samples etc.,).

Regards
Shiv Prasad

Edit: Full quote removed. [HS]

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
295 visitors (0 registered, 295 guests [including 18 identified bots]).
Forum time: 19:26 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5